NASDAQ:ABMD
Abiomed, Inc.
- Stock
Last Close
381.02
21/12 21:00
Market Cap
17.18B
Beta: -
Volume Today
15.70M
Avg: 1.70M
PE Ratio
126.85
PFCF: 68.83
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '14 | Mar '15 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | ||
|---|---|---|---|---|---|---|---|---|---|---|
revenue | 183.64M - | 230.31M 25.41% | 329.54M 43.09% | 445.30M 35.13% | 593.75M 33.34% | 769.43M 29.59% | 840.88M 9.29% | 847.52M 0.79% | 1.03B 21.74% | |
cost of revenue | 37.32M - | 39.95M 7.03% | 50.42M 26.22% | 70.63M 40.08% | 98.58M 39.58% | 129.57M 31.43% | 151.31M 16.78% | 161.91M 7.01% | 188.16M 16.21% | |
gross profit | 146.32M - | 190.37M 30.10% | 279.12M 46.62% | 374.68M 34.23% | 495.17M 32.16% | 639.87M 29.22% | 689.58M 7.77% | 685.62M 0.57% | 843.60M 23.04% | |
selling and marketing expenses | ||||||||||
general and administrative expenses | 107.25M - | 125.73M 17.23% | 164.26M 30.65% | 218.15M 32.81% | 262.73M 20.44% | 321.55M 22.39% | ||||
selling general and administrative expenses | 107.25M - | 125.73M 17.23% | 164.26M 30.65% | 218.15M 32.81% | 262.73M 20.44% | 321.55M 22.39% | 341.60M 6.24% | 334.18M 2.17% | 423.49M 26.72% | |
research and development expenses | 30.71M - | 35.97M 17.15% | 49.76M 38.32% | 66.39M 33.42% | 75.30M 13.42% | 93.50M 24.18% | 98.76M 5.62% | 121.88M 23.41% | 163.40M 34.07% | |
other expenses | 30.38M - | -4.56M 115.01% | 51.95M 1,238.92% | |||||||
cost and expenses | 175.28M - | 201.65M 15.04% | 264.44M 31.14% | 355.17M 34.31% | 436.61M 22.93% | 544.62M 24.74% | 591.66M 8.64% | 617.97M 4.45% | 775.05M 25.42% | |
operating expenses | 137.96M - | 161.70M 17.21% | 214.02M 32.36% | 284.54M 32.95% | 338.03M 18.80% | 415.05M 22.79% | 440.36M 6.10% | 456.06M 3.57% | 586.89M 28.69% | |
interest expense | 49.84M - | |||||||||
ebitda | 11.04M - | 31.54M 185.69% | 69.11M 119.17% | 97.55M 41.13% | 171.44M 75.76% | 230.77M 34.60% | 257.48M 11.58% | 246.94M 4.10% | 400.78M 62.30% | |
operating income | 8.36M - | 28.67M 242.77% | 65.10M 127.11% | 90.14M 38.45% | 157.14M 74.33% | 224.81M 43.07% | 249.22M 10.86% | 229.56M 7.89% | 372.69M 62.35% | |
depreciation and amortization | 2.51M - | 2.77M 10.45% | 3.28M 18.30% | 6.20M 89.26% | 11.01M 77.44% | 14.12M 28.31% | 8.26M 41.48% | 17.38M 110.34% | 28.09M 61.62% | |
total other income expenses net | 167K - | 99K 40.72% | 734K 641.41% | 1.21M 64.17% | 3.30M 173.86% | 38.55M 1,068.12% | 7.61M 80.27% | 58.66M 671.27% | -182.13M 410.47% | |
income before tax | 8.53M - | 28.77M 237.22% | 65.84M 128.88% | 91.34M 38.74% | 160.44M 75.64% | 263.36M 64.15% | 256.82M 2.48% | 288.22M 12.22% | 190.56M 33.88% | |
income tax expense | 1.18M - | -84.92M 7,302.97% | 27.69M 132.61% | 39.23M 41.66% | 48.27M 23.05% | 4.34M 91.00% | 53.82M 1,138.86% | 62.70M 16.50% | 54.05M 13.78% | |
net income | 7.35M - | 113.69M 1,446.57% | 38.15M 66.45% | 52.12M 36.62% | 112.17M 115.23% | 259.02M 130.91% | 203.01M 21.62% | 225.53M 11.09% | 136.50M 39.47% | |
weighted average shs out | 39.33M - | 40.63M 3.30% | 42.20M 3.87% | 43.24M 2.45% | 44.15M 2.12% | 44.91M 1.72% | 45.18M 0.60% | 45.14M 0.09% | 45.45M 0.68% | |
weighted average shs out dil | 41.61M - | 42.86M 3.01% | 44.90M 4.75% | 44.66M 0.53% | 45.85M 2.67% | 46.15M 0.66% | 45.82M 0.73% | 45.67M 0.31% | 45.88M 0.45% | |
eps | 0.19 - | 2.80 1,373.68% | 0.90 67.86% | 1.21 34.44% | 2.54 109.92% | 5.77 127.17% | 4.49 22.18% | 5 11.36% | 3 40% | |
epsdiluted | 0.18 - | 2.65 1,372.22% | 0.85 67.92% | 1.17 37.65% | 2.45 109.40% | 5.61 128.98% | 4.43 21.03% | 4.94 11.51% | 2.98 39.68% |
All numbers in USD (except ratios and percentages)